Sign In
Buy ORKLY
Orkla ASA Earnings Calls
| Release date | May 20, 2026 |
| EPS estimate | $0.178 |
| EPS actual | $0.180 |
| EPS Surprise | 0.90% |
| Revenue estimate | 1.874B |
| Revenue actual | 1.878B |
| Revenue Surprise | 0.213% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.141 |
| EPS actual | $0.170 |
| EPS Surprise | 21.00% |
| Revenue estimate | 1.854B |
| Revenue actual | 1.98B |
| Revenue Surprise | 6.84% |
| Release date | Nov 14, 2025 |
| EPS estimate | $0.164 |
| EPS actual | $0.180 |
| EPS Surprise | 9.76% |
| Revenue estimate | 1.759B |
| Revenue actual | 1.805B |
| Revenue Surprise | 2.59% |
| Release date | Jul 14, 2025 |
| EPS estimate | $0.151 |
| EPS actual | $0.150 |
| EPS Surprise | -0.332% |
| Revenue estimate | 1.743B |
| Revenue actual | 1.749B |
| Revenue Surprise | 0.314% |
Last 4 Quarters for Orkla ASA
Below you can see how ORKLY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 14, 2025 |
| Price on release | $10.71 |
| EPS estimate | $0.151 |
| EPS actual | $0.150 |
| EPS surprise | -0.332% |
| Date | Price |
|---|---|
| Jul 08, 2025 | $10.65 |
| Jul 09, 2025 | $10.80 |
| Jul 10, 2025 | $10.65 |
| Jul 11, 2025 | $10.59 |
| Jul 14, 2025 | $10.71 |
| Jul 15, 2025 | $10.56 |
| Jul 16, 2025 | $10.62 |
| Jul 17, 2025 | $10.80 |
| Jul 18, 2025 | $10.86 |
| 4 days before | 0.563% |
| 4 days after | 1.40% |
| On release day | -1.40% |
| Change in period | 1.97% |
| Release date | Nov 14, 2025 |
| Price on release | $10.63 |
| EPS estimate | $0.164 |
| EPS actual | $0.180 |
| EPS surprise | 9.76% |
| Date | Price |
|---|---|
| Nov 10, 2025 | $10.03 |
| Nov 11, 2025 | $10.12 |
| Nov 12, 2025 | $10.22 |
| Nov 13, 2025 | $10.14 |
| Nov 14, 2025 | $10.63 |
| Nov 17, 2025 | $10.50 |
| Nov 18, 2025 | $10.32 |
| Nov 19, 2025 | $10.33 |
| Nov 20, 2025 | $10.25 |
| 4 days before | 5.98% |
| 4 days after | -3.59% |
| On release day | -1.24% |
| Change in period | 2.17% |
| Release date | Feb 12, 2026 |
| Price on release | $13.60 |
| EPS estimate | $0.141 |
| EPS actual | $0.170 |
| EPS surprise | 21.00% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $12.51 |
| Feb 09, 2026 | $12.64 |
| Feb 10, 2026 | $12.75 |
| Feb 11, 2026 | $12.94 |
| Feb 12, 2026 | $13.60 |
| Feb 13, 2026 | $13.75 |
| Feb 17, 2026 | $13.67 |
| Feb 18, 2026 | $13.29 |
| Feb 19, 2026 | $13.33 |
| 4 days before | 8.67% |
| 4 days after | -1.95% |
| On release day | 1.14% |
| Change in period | 6.55% |
| Release date | May 20, 2026 |
| Price on release | $11.71 |
| EPS estimate | $0.178 |
| EPS actual | $0.180 |
| EPS surprise | 0.90% |
| Date | Price |
|---|---|
| May 14, 2026 | $11.92 |
| May 15, 2026 | $11.98 |
| May 18, 2026 | $12.30 |
| May 19, 2026 | $12.42 |
| May 20, 2026 | $11.71 |
| May 21, 2026 | $11.39 |
| May 22, 2026 | $11.41 |
| May 26, 2026 | $11.25 |
| May 27, 2026 | $11.30 |
| 4 days before | -1.76% |
| 4 days after | -3.50% |
| On release day | -2.73% |
| Change in period | -5.20% |
Orkla ASA Earnings Call Transcript Summary of Q1 2026
Orkla reported a solid first quarter with organic growth of 4.9% and underlying EBIT adjusted growth of 3%. Adjusted EPS increased 4% to NOK 1.75. Performance was broad-based: Jotun delivered particularly strong underlying EBIT growth (~16% for the quarter), Orkla Snacks and Orkla Food Ingredients also contributed positively, while Orkla Health underperformed (weak volumes, margin pressure and announced closure of three factories) and is expected to be a challenging year. Reported revenue rose modestly to NOK 17.4 billion; reported results were impacted by negative currency effects and lower contribution from Orkla Real Estate. Cash flow from operations was NOK 1.1 billion, and Orkla executed NOK 1.0 billion of share buybacks in the quarter. Net debt was NOK 13.6 billion (≈1x EBITDA), leaving the company with a strong balance sheet and flexibility for value-accretive actions. Management flagged upward pressure on energy, freight and packaging costs (portfolio- and region-specific) related to the Middle East conflict but said they do not currently expect inflationary effects on the scale of post-pandemic inflation. The company remains on track relative to its 3-year financial targets, with margins within target range and ROCE at 12.4%.
